Tg(ACTA1-ATP2A1*/DsRed/GFP)5Wheel
Transgene Detail
|
Symbol: |
Tg(ACTA1-ATP2A1*/DsRed/GFP)5Wheel |
Name: |
transgene insertion 5, Thurman Wheeler |
MGI ID: |
MGI:6272824 |
Synonyms: |
Therapy Reporter, TR |
Transgene: |
Tg(ACTA1-ATP2A1*/DsRed/GFP)5Wheel Location: unknown
|
Alliance: |
Tg(ACTA1-ATP2A1*/DsRed/GFP)5Wheel page
|
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Reporter) |
Mutation: |
|
Insertion
|
|
|
Mutation details: The transgenic construct is designed with a human skeletal actin (ACTA1 or HSA) promoter followed by a human ATP2A1 exon 22 minigene with a single base deletion to reduce the number of base pairs from 42 to 41. The deletion allows transcription to bypass a stop codon and shift the reading frame. The ATP2A1 minigene is followed by sequence from a DsRed reporter fused to a GFP reporter. If alternative splicing includes exon 22 then the DsRed sequence is in-frame; if exon 22 is skipped then the reading frame shifts to GFP. The bichromatic shift occurs because DsRed has two open reading frames.
(J:267578)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:267578 Hu N, et al., Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1. Nat Commun. 2018 Dec 7;9(1):5227 |
All: |
1 reference(s) |
|